Cartilage T2 Mapping

QUIBIM

QUIBIM has developed a non-invasive post-processing application to obtain cartilage the T2 mapping of the femoral cartilage using AI to automatically segment the cartilage. T2 mapping helps depicting changes and abnormalities in the cartilage matrix.

Product specifications

Information source: Vendor
Last updated: March 10, 2020

General
Product name	Cartilage T2 Mapping
Company	QUIBIM
Subspeciality	MSK
Modality	MR
Disease targeted	Osteoarthritis, Inflammatory disease, Cartilage quality, Degenerative disease, Sports-related diseases and conditions
Key-features	Automatic cartilage segmentation, T2 Values
Suggested use	Without interference of a radiologist: AI-only diagnosis
Data characteristics
Population	Patients with degenerative or inflammatory diseases of the joints
Input	MR 3D T2 Gradient Echo with high contrast between bone and cartilage T2 Multi-echo
Input format
Output	One-page structured report: 3D reconstruction of the femoral cartilage, T2 cartilage histogram, T2 values per parcel
Output format	DICOM Secondary Capture / PDF
Technology
Integration	Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased
Deployment	Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis	Automatically, right after the image acquisition
Processing time	1 - 10 minutes
Certification
CE	Certified, Class IIa
FDA	No or not yet
Market presence
On market since	01-2019
Distribution channels
Countries present (clinical, non-research use)	2
Paying clinical customers (institutes)	5+
Research/test users (institutes)	<5
Pricing
Pricing model	License
Based on	Number of installations, Number of analyses
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers